Kilitch Drugs Approves Key Appointments, Sets Date for 34th Annual General Meeting
Kilitch Drugs (India) Limited held its Board of Directors meeting on July 28, 2026, where it approved several operational and governance decisions. The Board concluded the meeting at 17:45 hours after commencing proceedings at 16:30 hours.Key outcomes of the board meeting included scheduling the company's 34th Annual General Meeting (AGM). The AGM for the financial year ended March 31, 2026, is scheduled to be held on Thursday, August 27, 2026, at 9:00 am. The meeting will be conducted exclusively through video conferencing and other audio visual means.
The Board also approved the Directors Report of the Company along with the Corporate Governance Report and all relevant annexures pertaining to the financial year 2025-26. To ensure transparency during the voting process, Mr. Deep Shukla, a Practicing Company Secretary, was appointed as the Scrutinizer for the 34th AGM (including e-voting).
Share Book Closure and Cost Auditor Reappointment
For the successful conduct of the company's 34th AGM, the Register of Members and Share Transfer Books shall be closed from Thursday, August 20, 2026, to Thursday, August 27, 2026.In addition, M/s Arvind Kumar & Co., Cost Accountants (Firm Registration No. 000646) were re-appointed as the Cost Auditors of Kilitch Drugs for the financial year 2026-27.
Details regarding the appointed cost auditing firm are as follows:
| Metric | Details |
|---|---|
| Firm Name | Arvind Kumar & Co., Cost Accountants |
| Partner Name | Mr. Arvind Kumar |
| Address | D - 202, 2nd Floor, Vrushali Shilp, Chikuvadi, Link Road, Borivali (W), Mumbai - 400092 |
| Membership No. | 37904 |
| Firm Registration number | 000646 |
| Area of experience | Accounts, Taxation (including international Taxation), ROC Matters, Internal Audits, Cost Audits |
| Relationship Disclosure | There is no relationship between directors and the cost auditor |
KILITCH Stock Price Movement
Today, Kilitch Drugs (India) Limited shares edged higher in post-market trading, closing at ₹183.59 after gaining 1.74%. The stock traded a total of 28,404 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.